Skin	O
Conductance	O
Responses	O
and	O
Neural	O
Activations	O
During	O
Fear	B:C0015726
Conditioning	O
and	O
Extinction	O
Recall	O
Across	O
Anxiety	O
Disorders	I:C0003469
.	O

Skin	O
Conductance	O
Responses	O
and	O
Neural	O
Activations	O
During	O
Fear	O
Conditioning	B:C0009647
and	O
Extinction	O
Recall	O
Across	O
Anxiety	O
Disorders	I:C0003469
.	O

Skin	O
Conductance	O
Responses	O
and	O
Neural	O
Activations	O
During	O
Fear	O
Conditioning	O
and	O
Extinction	B:C0015347
Recall	O
Across	O
Anxiety	O
Disorders	I:C0003469
.	O

Skin	O
Conductance	O
Responses	O
and	O
Neural	O
Activations	O
During	O
Fear	O
Conditioning	O
and	O
Extinction	O
Recall	B:C0034770
Across	O
Anxiety	O
Disorders	I:C0003469
.	O

Skin	O
Conductance	O
Responses	O
and	O
Neural	O
Activations	O
During	O
Fear	O
Conditioning	O
and	O
Extinction	O
Recall	O
Across	O
Anxiety	B:C0003469
Disorders	I:C0003469
.	O

The	O
fear	B:C0015726
conditioning	O
and	O
extinction	O
neurocircuitry	O
has	O
been	O
extensively	O
studied	O
in	O
healthy	O
and	O
clinical	O
populations	O
,	O
with	O
a	O
particular	O
focus	I:C0205234
on	O
posttraumatic	O
stress	I:C0038436
disorder	I:C0038436
.	O

The	O
fear	O
conditioning	B:C0009647
and	O
extinction	O
neurocircuitry	O
has	O
been	O
extensively	O
studied	O
in	O
healthy	O
and	O
clinical	O
populations	O
,	O
with	O
a	O
particular	O
focus	I:C0205234
on	O
posttraumatic	O
stress	I:C0038436
disorder	I:C0038436
.	O

The	O
fear	O
conditioning	O
and	O
extinction	B:C0015347
neurocircuitry	O
has	O
been	O
extensively	O
studied	O
in	O
healthy	O
and	O
clinical	O
populations	O
,	O
with	O
a	O
particular	O
focus	I:C0205234
on	O
posttraumatic	O
stress	I:C0038436
disorder	I:C0038436
.	O

The	O
fear	O
conditioning	O
and	O
extinction	O
neurocircuitry	O
has	O
been	O
extensively	O
studied	B:C2603343
in	O
healthy	O
and	O
clinical	O
populations	O
,	O
with	O
a	O
particular	O
focus	I:C0205234
on	O
posttraumatic	O
stress	I:C0038436
disorder	I:C0038436
.	O

The	O
fear	O
conditioning	O
and	O
extinction	O
neurocircuitry	O
has	O
been	O
extensively	O
studied	O
in	O
healthy	O
and	O
clinical	O
populations	B:C1257890
,	O
with	O
a	O
particular	O
focus	I:C0205234
on	O
posttraumatic	O
stress	I:C0038436
disorder	I:C0038436
.	O

The	O
fear	O
conditioning	O
and	O
extinction	O
neurocircuitry	O
has	O
been	O
extensively	O
studied	O
in	O
healthy	O
and	O
clinical	O
populations	O
,	O
with	O
a	O
particular	B:C0205234
focus	I:C0205234
on	O
posttraumatic	O
stress	I:C0038436
disorder	I:C0038436
.	O

The	O
fear	O
conditioning	O
and	O
extinction	O
neurocircuitry	O
has	O
been	O
extensively	O
studied	O
in	O
healthy	O
and	O
clinical	O
populations	O
,	O
with	O
a	O
particular	O
focus	I:C0205234
on	O
posttraumatic	B:C0038436
stress	I:C0038436
disorder	I:C0038436
.	O

Despite	O
significant	O
overlap	O
of	O
symptoms	B:C1457887
between	O
posttraumatic	O
stress	I:C0038436
disorder	I:C0038436
and	O
anxiety	O
disorders	I:C0003469
,	O
the	O
latter	O
has	O
received	O
less	O
attention	O
.	O

Despite	O
significant	O
overlap	O
of	O
symptoms	O
between	O
posttraumatic	B:C0038436
stress	I:C0038436
disorder	I:C0038436
and	O
anxiety	O
disorders	I:C0003469
,	O
the	O
latter	O
has	O
received	O
less	O
attention	O
.	O

Despite	O
significant	O
overlap	O
of	O
symptoms	O
between	O
posttraumatic	O
stress	I:C0038436
disorder	I:C0038436
and	O
anxiety	B:C0003469
disorders	I:C0003469
,	O
the	O
latter	O
has	O
received	O
less	O
attention	O
.	O

Despite	O
significant	O
overlap	O
of	O
symptoms	O
between	O
posttraumatic	O
stress	I:C0038436
disorder	I:C0038436
and	O
anxiety	O
disorders	I:C0003469
,	O
the	O
latter	O
has	O
received	O
less	O
attention	B:C0004268
.	O

Given	O
that	O
dysregulated	O
fear	B:C0015726
levels	O
characterize	O
anxiety	O
disorders	I:C0003469
,	O
examining	O
the	O
neural	O
correlates	O
of	O
fear	O
and	O
extinction	O
learning	O
may	O
shed	O
light	O
on	O
the	O
pathogenesis	O
of	O
underlying	O
anxiety	O
disorders	I:C0003469
.	O

Given	O
that	O
dysregulated	O
fear	O
levels	O
characterize	O
anxiety	B:C0003469
disorders	I:C0003469
,	O
examining	O
the	O
neural	O
correlates	O
of	O
fear	O
and	O
extinction	O
learning	O
may	O
shed	O
light	O
on	O
the	O
pathogenesis	O
of	O
underlying	O
anxiety	O
disorders	I:C0003469
.	O

Given	O
that	O
dysregulated	O
fear	O
levels	O
characterize	O
anxiety	O
disorders	I:C0003469
,	O
examining	B:C0582103
the	O
neural	O
correlates	O
of	O
fear	O
and	O
extinction	O
learning	O
may	O
shed	O
light	O
on	O
the	O
pathogenesis	O
of	O
underlying	O
anxiety	O
disorders	I:C0003469
.	O

Given	O
that	O
dysregulated	O
fear	O
levels	O
characterize	O
anxiety	O
disorders	I:C0003469
,	O
examining	O
the	O
neural	O
correlates	O
of	O
fear	B:C0015726
and	O
extinction	O
learning	O
may	O
shed	O
light	O
on	O
the	O
pathogenesis	O
of	O
underlying	O
anxiety	O
disorders	I:C0003469
.	O

Given	O
that	O
dysregulated	O
fear	O
levels	O
characterize	O
anxiety	O
disorders	I:C0003469
,	O
examining	O
the	O
neural	O
correlates	O
of	O
fear	O
and	O
extinction	B:C0015347
learning	O
may	O
shed	O
light	O
on	O
the	O
pathogenesis	O
of	O
underlying	O
anxiety	O
disorders	I:C0003469
.	O

Given	O
that	O
dysregulated	O
fear	O
levels	O
characterize	O
anxiety	O
disorders	I:C0003469
,	O
examining	O
the	O
neural	O
correlates	O
of	O
fear	O
and	O
extinction	O
learning	B:C0023185
may	O
shed	O
light	O
on	O
the	O
pathogenesis	O
of	O
underlying	O
anxiety	O
disorders	I:C0003469
.	O

Given	O
that	O
dysregulated	O
fear	O
levels	O
characterize	O
anxiety	O
disorders	I:C0003469
,	O
examining	O
the	O
neural	O
correlates	O
of	O
fear	O
and	O
extinction	O
learning	O
may	O
shed	O
light	O
on	O
the	O
pathogenesis	B:C0699748
of	O
underlying	O
anxiety	O
disorders	I:C0003469
.	O

Given	O
that	O
dysregulated	O
fear	O
levels	O
characterize	O
anxiety	O
disorders	I:C0003469
,	O
examining	O
the	O
neural	O
correlates	O
of	O
fear	O
and	O
extinction	O
learning	O
may	O
shed	O
light	O
on	O
the	O
pathogenesis	O
of	O
underlying	O
anxiety	B:C0003469
disorders	I:C0003469
.	O

To	O
investigate	O
the	O
psychophysiological	B:C0018467
and	O
neural	O
correlates	O
of	O
fear	O
conditioning	O
and	O
extinction	O
recall	O
in	O
anxiety	O
disorders	I:C0003469
and	O
to	O
document	O
how	O
these	O
features	O
differ	O
as	O
a	O
function	O
of	O
multiple	O
diagnoses	O
or	O
anxiety	O
severity	O
.	O

To	O
investigate	O
the	O
psychophysiological	O
and	O
neural	O
correlates	O
of	O
fear	B:C0015726
conditioning	O
and	O
extinction	O
recall	O
in	O
anxiety	O
disorders	I:C0003469
and	O
to	O
document	O
how	O
these	O
features	O
differ	O
as	O
a	O
function	O
of	O
multiple	O
diagnoses	O
or	O
anxiety	O
severity	O
.	O

To	O
investigate	O
the	O
psychophysiological	O
and	O
neural	O
correlates	O
of	O
fear	O
conditioning	B:C0009647
and	O
extinction	O
recall	O
in	O
anxiety	O
disorders	I:C0003469
and	O
to	O
document	O
how	O
these	O
features	O
differ	O
as	O
a	O
function	O
of	O
multiple	O
diagnoses	O
or	O
anxiety	O
severity	O
.	O

To	O
investigate	O
the	O
psychophysiological	O
and	O
neural	O
correlates	O
of	O
fear	O
conditioning	O
and	O
extinction	B:C0015347
recall	O
in	O
anxiety	O
disorders	I:C0003469
and	O
to	O
document	O
how	O
these	O
features	O
differ	O
as	O
a	O
function	O
of	O
multiple	O
diagnoses	O
or	O
anxiety	O
severity	O
.	O

To	O
investigate	O
the	O
psychophysiological	O
and	O
neural	O
correlates	O
of	O
fear	O
conditioning	O
and	O
extinction	O
recall	B:C0034770
in	O
anxiety	O
disorders	I:C0003469
and	O
to	O
document	O
how	O
these	O
features	O
differ	O
as	O
a	O
function	O
of	O
multiple	O
diagnoses	O
or	O
anxiety	O
severity	O
.	O

To	O
investigate	O
the	O
psychophysiological	O
and	O
neural	O
correlates	O
of	O
fear	O
conditioning	O
and	O
extinction	O
recall	O
in	O
anxiety	B:C0003469
disorders	I:C0003469
and	O
to	O
document	O
how	O
these	O
features	O
differ	O
as	O
a	O
function	O
of	O
multiple	O
diagnoses	O
or	O
anxiety	O
severity	O
.	O

To	O
investigate	O
the	O
psychophysiological	O
and	O
neural	O
correlates	O
of	O
fear	O
conditioning	O
and	O
extinction	O
recall	O
in	O
anxiety	O
disorders	I:C0003469
and	O
to	O
document	B:C1301746
how	O
these	O
features	O
differ	O
as	O
a	O
function	O
of	O
multiple	O
diagnoses	O
or	O
anxiety	O
severity	O
.	O

To	O
investigate	O
the	O
psychophysiological	O
and	O
neural	O
correlates	O
of	O
fear	O
conditioning	O
and	O
extinction	O
recall	O
in	O
anxiety	O
disorders	I:C0003469
and	O
to	O
document	O
how	O
these	O
features	O
differ	O
as	O
a	O
function	O
of	O
multiple	O
diagnoses	B:C0011900
or	O
anxiety	O
severity	O
.	O

To	O
investigate	O
the	O
psychophysiological	O
and	O
neural	O
correlates	O
of	O
fear	O
conditioning	O
and	O
extinction	O
recall	O
in	O
anxiety	O
disorders	I:C0003469
and	O
to	O
document	O
how	O
these	O
features	O
differ	O
as	O
a	O
function	O
of	O
multiple	O
diagnoses	O
or	O
anxiety	B:C0003467
severity	O
.	O

This	O
investigation	B:C0220825
was	O
a	O
cross-sectional	O
,	O
case	O
-	I:C0872128
control	I:C0872128
,	O
functional	O
magnetic	I:C0376335
resonance	I:C0376335
imaging	I:C0376335
study	O
at	O
an	O
academic	O
medical	I:C0000872
center	I:C0000872
.	O

This	O
investigation	O
was	O
a	O
cross-sectional	B:C0010362
,	O
case	O
-	I:C0872128
control	I:C0872128
,	O
functional	O
magnetic	I:C0376335
resonance	I:C0376335
imaging	I:C0376335
study	O
at	O
an	O
academic	O
medical	I:C0000872
center	I:C0000872
.	O

This	O
investigation	O
was	O
a	O
cross-sectional	O
,	O
case	B:C0872128
-	I:C0872128
control	I:C0872128
,	O
functional	O
magnetic	I:C0376335
resonance	I:C0376335
imaging	I:C0376335
study	O
at	O
an	O
academic	O
medical	I:C0000872
center	I:C0000872
.	O

This	O
investigation	O
was	O
a	O
cross-sectional	O
,	O
case	O
-	I:C0872128
control	I:C0872128
,	O
functional	B:C0376335
magnetic	I:C0376335
resonance	I:C0376335
imaging	I:C0376335
study	O
at	O
an	O
academic	O
medical	I:C0000872
center	I:C0000872
.	O

This	O
investigation	O
was	O
a	O
cross-sectional	O
,	O
case	O
-	I:C0872128
control	I:C0872128
,	O
functional	O
magnetic	I:C0376335
resonance	I:C0376335
imaging	I:C0376335
study	B:C2603343
at	O
an	O
academic	O
medical	I:C0000872
center	I:C0000872
.	O

This	O
investigation	O
was	O
a	O
cross-sectional	O
,	O
case	O
-	I:C0872128
control	I:C0872128
,	O
functional	O
magnetic	I:C0376335
resonance	I:C0376335
imaging	I:C0376335
study	O
at	O
an	O
academic	B:C0000872
medical	I:C0000872
center	I:C0000872
.	O

Participants	B:C0679646
were	O
healthy	O
controls	O
and	O
individuals	O
with	O
at	O
least	O
1	O
of	O
the	O
following	O
anxiety	O
disorders	I:C0003469
:	O
generalized	O
anxiety	I:C0270549
disorder	I:C0270549
,	O
social	O
anxiety	O
disorder	O
,	O
specific	O
phobia	I:C0236801
,	O
and	O
panic	O
disorder	I:C0030319
.	O

Participants	O
were	O
healthy	O
controls	O
and	O
individuals	B:C0237401
with	O
at	O
least	O
1	O
of	O
the	O
following	O
anxiety	O
disorders	I:C0003469
:	O
generalized	O
anxiety	I:C0270549
disorder	I:C0270549
,	O
social	O
anxiety	O
disorder	O
,	O
specific	O
phobia	I:C0236801
,	O
and	O
panic	O
disorder	I:C0030319
.	O

Participants	O
were	O
healthy	O
controls	O
and	O
individuals	O
with	O
at	O
least	O
1	O
of	O
the	O
following	O
anxiety	B:C0003469
disorders	I:C0003469
:	O
generalized	O
anxiety	I:C0270549
disorder	I:C0270549
,	O
social	O
anxiety	O
disorder	O
,	O
specific	O
phobia	I:C0236801
,	O
and	O
panic	O
disorder	I:C0030319
.	O

Participants	O
were	O
healthy	O
controls	O
and	O
individuals	O
with	O
at	O
least	O
1	O
of	O
the	O
following	O
anxiety	O
disorders	I:C0003469
:	O
generalized	B:C0270549
anxiety	I:C0270549
disorder	I:C0270549
,	O
social	O
anxiety	O
disorder	O
,	O
specific	O
phobia	I:C0236801
,	O
and	O
panic	O
disorder	I:C0030319
.	O

Participants	O
were	O
healthy	O
controls	O
and	O
individuals	O
with	O
at	O
least	O
1	O
of	O
the	O
following	O
anxiety	O
disorders	I:C0003469
:	O
generalized	O
anxiety	I:C0270549
disorder	I:C0270549
,	O
social	O
anxiety	O
disorder	O
,	O
specific	B:C0236801
phobia	I:C0236801
,	O
and	O
panic	O
disorder	I:C0030319
.	O

Participants	O
were	O
healthy	O
controls	O
and	O
individuals	O
with	O
at	O
least	O
1	O
of	O
the	O
following	O
anxiety	O
disorders	I:C0003469
:	O
generalized	O
anxiety	I:C0270549
disorder	I:C0270549
,	O
social	O
anxiety	O
disorder	O
,	O
specific	O
phobia	I:C0236801
,	O
and	O
panic	B:C0030319
disorder	I:C0030319
.	O

The	O
study	B:C2603343
dates	O
were	O
between	O
March	O
2013	O
and	O
May	O
2015	O
.	O

Two	O
-	O
day	O
fear	B:C0015726
conditioning	O
and	O
extinction	O
paradigm	O
.	O

Two	O
-	O
day	O
fear	O
conditioning	B:C0009647
and	O
extinction	O
paradigm	O
.	O

Two	O
-	O
day	O
fear	O
conditioning	O
and	O
extinction	B:C0015347
paradigm	O
.	O

Skin	O
conductance	O
responses	O
,	O
blood	B:C1655730
oxygenation	I:C1655730
level	I:C1655730
-	I:C1655730
dependent	I:C1655730
responses	O
,	O
trait	O
anxiety	O
scores	O
from	O
the	O
State	O
Trait	I:C0683457
Anxiety	I:C0683457
Inventory	I:C0683457
-	O
Trait	O
Form	O
,	O
and	O
functiona	O
l	O
connectivity	O
.	O

Skin	O
conductance	O
responses	O
,	O
blood	O
oxygenation	I:C1655730
level	I:C1655730
-	I:C1655730
dependent	I:C1655730
responses	O
,	O
trait	O
anxiety	O
scores	O
from	O
the	O
State	B:C0683457
Trait	I:C0683457
Anxiety	I:C0683457
Inventory	I:C0683457
-	O
Trait	O
Form	O
,	O
and	O
functiona	O
l	O
connectivity	O
.	O

This	O
study	B:C2603343
included	O
21	O
healthy	O
controls	O
(	O
10	O
women	O
)	O
and	O
61	O
individuals	O
with	O
anxiety	O
disorders	I:C0003469
(	O
36	O
women	O
)	O
.	O

This	O
study	O
included	O
21	O
healthy	O
controls	O
(	O
10	O
women	B:C0043210
)	O
and	O
61	O
individuals	O
with	O
anxiety	O
disorders	I:C0003469
(	O
36	O
women	O
)	O
.	O

This	O
study	O
included	O
21	O
healthy	O
controls	O
(	O
10	O
women	O
)	O
and	O
61	O
individuals	B:C0237401
with	O
anxiety	O
disorders	I:C0003469
(	O
36	O
women	O
)	O
.	O

This	O
study	O
included	O
21	O
healthy	O
controls	O
(	O
10	O
women	O
)	O
and	O
61	O
individuals	O
with	O
anxiety	B:C0003469
disorders	I:C0003469
(	O
36	O
women	O
)	O
.	O

This	O
study	O
included	O
21	O
healthy	O
controls	O
(	O
10	O
women	O
)	O
and	O
61	O
individuals	O
with	O
anxiety	O
disorders	I:C0003469
(	O
36	O
women	B:C0043210
)	O
.	O

P	O
values	O
reported	B:C0700287
for	O
the	O
neuroimaging	O
results	O
are	O
all	O
familywise	O
error	O
corrected	O
.	O

P	O
values	O
reported	O
for	O
the	O
neuroimaging	B:C0679575
results	O
are	O
all	O
familywise	O
error	O
corrected	O
.	O

P	O
values	O
reported	O
for	O
the	O
neuroimaging	O
results	B:C0456984
are	O
all	O
familywise	O
error	O
corrected	O
.	O

Skin	O
conductance	O
responses	O
during	O
extinction	B:C0015347
recall	O
did	O
not	O
differ	O
between	O
individuals	O
with	O
anxiety	O
disorders	I:C0003469
and	O
healthy	O
controls	O
(	O
ηp2	O
=	O
0.001	O
,	O
P	O
=	O
.79	O
)	O
,	O
where	O
ηp2	O
is	O
partial	O
eta	O
squared	O
.	O

Skin	O
conductance	O
responses	O
during	O
extinction	O
recall	B:C0034770
did	O
not	O
differ	O
between	O
individuals	O
with	O
anxiety	O
disorders	I:C0003469
and	O
healthy	O
controls	O
(	O
ηp2	O
=	O
0.001	O
,	O
P	O
=	O
.79	O
)	O
,	O
where	O
ηp2	O
is	O
partial	O
eta	O
squared	O
.	O

Skin	O
conductance	O
responses	O
during	O
extinction	O
recall	O
did	O
not	O
differ	O
between	O
individuals	B:C0237401
with	O
anxiety	O
disorders	I:C0003469
and	O
healthy	O
controls	O
(	O
ηp2	O
=	O
0.001	O
,	O
P	O
=	O
.79	O
)	O
,	O
where	O
ηp2	O
is	O
partial	O
eta	O
squared	O
.	O

Skin	O
conductance	O
responses	O
during	O
extinction	O
recall	O
did	O
not	O
differ	O
between	O
individuals	O
with	O
anxiety	B:C0003469
disorders	I:C0003469
and	O
healthy	O
controls	O
(	O
ηp2	O
=	O
0.001	O
,	O
P	O
=	O
.79	O
)	O
,	O
where	O
ηp2	O
is	O
partial	O
eta	O
squared	O
.	O

The	O
anxiety	B:C0003467
group	O
had	O
lower	O
activation	O
of	O
the	O
ventromedial	O
prefrontal	I:C3850122
cortex	I:C3850122
(	O
ventromedial	O
prefrontal	I:C3850122
cortex	I:C3850122
)	O
during	O
extinction	O
recall	O
(	O
ηp2	O
=	O
0.178	O
,	O
P	O
=	O
.02	O
)	O
.	O

The	O
anxiety	O
group	B:C1257890
had	O
lower	O
activation	O
of	O
the	O
ventromedial	O
prefrontal	I:C3850122
cortex	I:C3850122
(	O
ventromedial	O
prefrontal	I:C3850122
cortex	I:C3850122
)	O
during	O
extinction	O
recall	O
(	O
ηp2	O
=	O
0.178	O
,	O
P	O
=	O
.02	O
)	O
.	O

The	O
anxiety	O
group	O
had	O
lower	O
activation	O
of	O
the	O
ventromedial	B:C3850122
prefrontal	I:C3850122
cortex	I:C3850122
(	O
ventromedial	O
prefrontal	I:C3850122
cortex	I:C3850122
)	O
during	O
extinction	O
recall	O
(	O
ηp2	O
=	O
0.178	O
,	O
P	O
=	O
.02	O
)	O
.	O

The	O
anxiety	O
group	O
had	O
lower	O
activation	O
of	O
the	O
ventromedial	O
prefrontal	I:C3850122
cortex	I:C3850122
(	O
ventromedial	B:C3850122
prefrontal	I:C3850122
cortex	I:C3850122
)	O
during	O
extinction	O
recall	O
(	O
ηp2	O
=	O
0.178	O
,	O
P	O
=	O
.02	O
)	O
.	O

The	O
anxiety	O
group	O
had	O
lower	O
activation	O
of	O
the	O
ventromedial	O
prefrontal	I:C3850122
cortex	I:C3850122
(	O
ventromedial	O
prefrontal	I:C3850122
cortex	I:C3850122
)	O
during	O
extinction	B:C0015347
recall	O
(	O
ηp2	O
=	O
0.178	O
,	O
P	O
=	O
.02	O
)	O
.	O

The	O
anxiety	O
group	O
had	O
lower	O
activation	O
of	O
the	O
ventromedial	O
prefrontal	I:C3850122
cortex	I:C3850122
(	O
ventromedial	O
prefrontal	I:C3850122
cortex	I:C3850122
)	O
during	O
extinction	O
recall	B:C0034770
(	O
ηp2	O
=	O
0.178	O
,	O
P	O
=	O
.02	O
)	O
.	O

A	O
similar	O
hypoactive	B:C0086439
pattern	O
was	O
found	O
during	O
early	O
conditioning	O
(	O
ηp2	O
=	O
0.106	O
,	O
P	O
=	O
.009	O
)	O
.	O

A	O
similar	O
hypoactive	O
pattern	B:C0449774
was	O
found	O
during	O
early	O
conditioning	O
(	O
ηp2	O
=	O
0.106	O
,	O
P	O
=	O
.009	O
)	O
.	O

A	O
similar	O
hypoactive	O
pattern	O
was	O
found	O
during	O
early	O
conditioning	B:C0009647
(	O
ηp2	O
=	O
0.106	O
,	O
P	O
=	O
.009	O
)	O
.	O

The	O
ventromedial	B:C3850122
prefrontal	I:C3850122
cortex	I:C3850122
hypoactivation	O
was	O
associated	O
with	O
anxiety	O
symptom	I:C0860603
severity	O
(	O
r	O
=	O
-	O
0.420	O
,	O
P	O
=	O
.01	O
for	O
conditioning	O
and	O
r	O
=	O
-	O
0.464	O
,	O
P	O
=	O
.004	O
for	O
extinction	O
recall	O
)	O
and	O
the	O
number	O
of	O
co-occuring	O
anxiety	O
disorders	I:C0003469
diagnosed	O
(	O
ηp2	O
=	O
0.137	O
,	O
P	O
=	O
.009	O
for	O
conditioning	O
and	O
η	O
p2	O
=	O
0.227	O
,	O
P	O
=	O
.004	O
for	O
extinction	O
recall	O
)	O
.	O

The	O
ventromedial	O
prefrontal	I:C3850122
cortex	I:C3850122
hypoactivation	O
was	O
associated	O
with	O
anxiety	B:C0860603
symptom	I:C0860603
severity	O
(	O
r	O
=	O
-	O
0.420	O
,	O
P	O
=	O
.01	O
for	O
conditioning	O
and	O
r	O
=	O
-	O
0.464	O
,	O
P	O
=	O
.004	O
for	O
extinction	O
recall	O
)	O
and	O
the	O
number	O
of	O
co-occuring	O
anxiety	O
disorders	I:C0003469
diagnosed	O
(	O
ηp2	O
=	O
0.137	O
,	O
P	O
=	O
.009	O
for	O
conditioning	O
and	O
η	O
p2	O
=	O
0.227	O
,	O
P	O
=	O
.004	O
for	O
extinction	O
recall	O
)	O
.	O

The	O
ventromedial	O
prefrontal	I:C3850122
cortex	I:C3850122
hypoactivation	O
was	O
associated	O
with	O
anxiety	O
symptom	I:C0860603
severity	O
(	O
r	O
=	O
-	O
0.420	O
,	O
P	O
=	O
.01	O
for	O
conditioning	B:C0009647
and	O
r	O
=	O
-	O
0.464	O
,	O
P	O
=	O
.004	O
for	O
extinction	O
recall	O
)	O
and	O
the	O
number	O
of	O
co-occuring	O
anxiety	O
disorders	I:C0003469
diagnosed	O
(	O
ηp2	O
=	O
0.137	O
,	O
P	O
=	O
.009	O
for	O
conditioning	O
and	O
η	O
p2	O
=	O
0.227	O
,	O
P	O
=	O
.004	O
for	O
extinction	O
recall	O
)	O
.	O

The	O
ventromedial	O
prefrontal	I:C3850122
cortex	I:C3850122
hypoactivation	O
was	O
associated	O
with	O
anxiety	O
symptom	I:C0860603
severity	O
(	O
r	O
=	O
-	O
0.420	O
,	O
P	O
=	O
.01	O
for	O
conditioning	O
and	O
r	O
=	O
-	O
0.464	O
,	O
P	O
=	O
.004	O
for	O
extinction	B:C0015347
recall	O
)	O
and	O
the	O
number	O
of	O
co-occuring	O
anxiety	O
disorders	I:C0003469
diagnosed	O
(	O
ηp2	O
=	O
0.137	O
,	O
P	O
=	O
.009	O
for	O
conditioning	O
and	O
η	O
p2	O
=	O
0.227	O
,	O
P	O
=	O
.004	O
for	O
extinction	O
recall	O
)	O
.	O

The	O
ventromedial	O
prefrontal	I:C3850122
cortex	I:C3850122
hypoactivation	O
was	O
associated	O
with	O
anxiety	O
symptom	I:C0860603
severity	O
(	O
r	O
=	O
-	O
0.420	O
,	O
P	O
=	O
.01	O
for	O
conditioning	O
and	O
r	O
=	O
-	O
0.464	O
,	O
P	O
=	O
.004	O
for	O
extinction	O
recall	B:C0034770
)	O
and	O
the	O
number	O
of	O
co-occuring	O
anxiety	O
disorders	I:C0003469
diagnosed	O
(	O
ηp2	O
=	O
0.137	O
,	O
P	O
=	O
.009	O
for	O
conditioning	O
and	O
η	O
p2	O
=	O
0.227	O
,	O
P	O
=	O
.004	O
for	O
extinction	O
recall	O
)	O
.	O

The	O
ventromedial	O
prefrontal	I:C3850122
cortex	I:C3850122
hypoactivation	O
was	O
associated	O
with	O
anxiety	O
symptom	I:C0860603
severity	O
(	O
r	O
=	O
-	O
0.420	O
,	O
P	O
=	O
.01	O
for	O
conditioning	O
and	O
r	O
=	O
-	O
0.464	O
,	O
P	O
=	O
.004	O
for	O
extinction	O
recall	O
)	O
and	O
the	O
number	O
of	O
co-occuring	O
anxiety	B:C0003469
disorders	I:C0003469
diagnosed	O
(	O
ηp2	O
=	O
0.137	O
,	O
P	O
=	O
.009	O
for	O
conditioning	O
and	O
η	O
p2	O
=	O
0.227	O
,	O
P	O
=	O
.004	O
for	O
extinction	O
recall	O
)	O
.	O

The	O
ventromedial	O
prefrontal	I:C3850122
cortex	I:C3850122
hypoactivation	O
was	O
associated	O
with	O
anxiety	O
symptom	I:C0860603
severity	O
(	O
r	O
=	O
-	O
0.420	O
,	O
P	O
=	O
.01	O
for	O
conditioning	O
and	O
r	O
=	O
-	O
0.464	O
,	O
P	O
=	O
.004	O
for	O
extinction	O
recall	O
)	O
and	O
the	O
number	O
of	O
co-occuring	O
anxiety	O
disorders	I:C0003469
diagnosed	B:C0011900
(	O
ηp2	O
=	O
0.137	O
,	O
P	O
=	O
.009	O
for	O
conditioning	O
and	O
η	O
p2	O
=	O
0.227	O
,	O
P	O
=	O
.004	O
for	O
extinction	O
recall	O
)	O
.	O

The	O
ventromedial	O
prefrontal	I:C3850122
cortex	I:C3850122
hypoactivation	O
was	O
associated	O
with	O
anxiety	O
symptom	I:C0860603
severity	O
(	O
r	O
=	O
-	O
0.420	O
,	O
P	O
=	O
.01	O
for	O
conditioning	O
and	O
r	O
=	O
-	O
0.464	O
,	O
P	O
=	O
.004	O
for	O
extinction	O
recall	O
)	O
and	O
the	O
number	O
of	O
co-occuring	O
anxiety	O
disorders	I:C0003469
diagnosed	O
(	O
ηp2	O
=	O
0.137	O
,	O
P	O
=	O
.009	O
for	O
conditioning	B:C0009647
and	O
η	O
p2	O
=	O
0.227	O
,	O
P	O
=	O
.004	O
for	O
extinction	O
recall	O
)	O
.	O

The	O
ventromedial	O
prefrontal	I:C3850122
cortex	I:C3850122
hypoactivation	O
was	O
associated	O
with	O
anxiety	O
symptom	I:C0860603
severity	O
(	O
r	O
=	O
-	O
0.420	O
,	O
P	O
=	O
.01	O
for	O
conditioning	O
and	O
r	O
=	O
-	O
0.464	O
,	O
P	O
=	O
.004	O
for	O
extinction	O
recall	O
)	O
and	O
the	O
number	O
of	O
co-occuring	O
anxiety	O
disorders	I:C0003469
diagnosed	O
(	O
ηp2	O
=	O
0.137	O
,	O
P	O
=	O
.009	O
for	O
conditioning	O
and	O
η	O
p2	O
=	O
0.227	O
,	O
P	O
=	O
.004	O
for	O
extinction	B:C0015347
recall	O
)	O
.	O

The	O
ventromedial	O
prefrontal	I:C3850122
cortex	I:C3850122
hypoactivation	O
was	O
associated	O
with	O
anxiety	O
symptom	I:C0860603
severity	O
(	O
r	O
=	O
-	O
0.420	O
,	O
P	O
=	O
.01	O
for	O
conditioning	O
and	O
r	O
=	O
-	O
0.464	O
,	O
P	O
=	O
.004	O
for	O
extinction	O
recall	O
)	O
and	O
the	O
number	O
of	O
co-occuring	O
anxiety	O
disorders	I:C0003469
diagnosed	O
(	O
ηp2	O
=	O
0.137	O
,	O
P	O
=	O
.009	O
for	O
conditioning	O
and	O
η	O
p2	O
=	O
0.227	O
,	O
P	O
=	O
.004	O
for	O
extinction	O
recall	B:C0034770
)	O
.	O

Psychophysiological	B:C0018467
interaction	O
analyses	O
revealed	O
that	O
the	O
fear	O
network	O
connectivity	I:C0598941
differed	O
between	O
healthy	O
controls	O
and	O
the	O
anxiety	O
group	O
during	O
fear	O
learning	O
(	O
ηp2	O
range	O
between	O
0.088	O
and	O
0.176	O
and	O
P	O
range	O
between	O
0.02	O
and	O
0.003	O
)	O
and	O
extinction	O
recall	O
(	O
ηp2	O
range	O
between	O
0.111	O
and	O
0.235	O
and	O
P	O
range	O
between	O
0.02	O
and	O
0.002	O
)	O
.	O

Psychophysiological	O
interaction	O
analyses	O
revealed	O
that	O
the	O
fear	B:C0015726
network	O
connectivity	I:C0598941
differed	O
between	O
healthy	O
controls	O
and	O
the	O
anxiety	O
group	O
during	O
fear	O
learning	O
(	O
ηp2	O
range	O
between	O
0.088	O
and	O
0.176	O
and	O
P	O
range	O
between	O
0.02	O
and	O
0.003	O
)	O
and	O
extinction	O
recall	O
(	O
ηp2	O
range	O
between	O
0.111	O
and	O
0.235	O
and	O
P	O
range	O
between	O
0.02	O
and	O
0.002	O
)	O
.	O

Psychophysiological	O
interaction	O
analyses	O
revealed	O
that	O
the	O
fear	O
network	B:C0598941
connectivity	I:C0598941
differed	O
between	O
healthy	O
controls	O
and	O
the	O
anxiety	O
group	O
during	O
fear	O
learning	O
(	O
ηp2	O
range	O
between	O
0.088	O
and	O
0.176	O
and	O
P	O
range	O
between	O
0.02	O
and	O
0.003	O
)	O
and	O
extinction	O
recall	O
(	O
ηp2	O
range	O
between	O
0.111	O
and	O
0.235	O
and	O
P	O
range	O
between	O
0.02	O
and	O
0.002	O
)	O
.	O

Psychophysiological	O
interaction	O
analyses	O
revealed	O
that	O
the	O
fear	O
network	O
connectivity	I:C0598941
differed	O
between	O
healthy	O
controls	O
and	O
the	O
anxiety	B:C0003467
group	O
during	O
fear	O
learning	O
(	O
ηp2	O
range	O
between	O
0.088	O
and	O
0.176	O
and	O
P	O
range	O
between	O
0.02	O
and	O
0.003	O
)	O
and	O
extinction	O
recall	O
(	O
ηp2	O
range	O
between	O
0.111	O
and	O
0.235	O
and	O
P	O
range	O
between	O
0.02	O
and	O
0.002	O
)	O
.	O

Psychophysiological	O
interaction	O
analyses	O
revealed	O
that	O
the	O
fear	O
network	O
connectivity	I:C0598941
differed	O
between	O
healthy	O
controls	O
and	O
the	O
anxiety	O
group	B:C1257890
during	O
fear	O
learning	O
(	O
ηp2	O
range	O
between	O
0.088	O
and	O
0.176	O
and	O
P	O
range	O
between	O
0.02	O
and	O
0.003	O
)	O
and	O
extinction	O
recall	O
(	O
ηp2	O
range	O
between	O
0.111	O
and	O
0.235	O
and	O
P	O
range	O
between	O
0.02	O
and	O
0.002	O
)	O
.	O

Psychophysiological	O
interaction	O
analyses	O
revealed	O
that	O
the	O
fear	O
network	O
connectivity	I:C0598941
differed	O
between	O
healthy	O
controls	O
and	O
the	O
anxiety	O
group	O
during	O
fear	B:C0015726
learning	O
(	O
ηp2	O
range	O
between	O
0.088	O
and	O
0.176	O
and	O
P	O
range	O
between	O
0.02	O
and	O
0.003	O
)	O
and	O
extinction	O
recall	O
(	O
ηp2	O
range	O
between	O
0.111	O
and	O
0.235	O
and	O
P	O
range	O
between	O
0.02	O
and	O
0.002	O
)	O
.	O

Psychophysiological	O
interaction	O
analyses	O
revealed	O
that	O
the	O
fear	O
network	O
connectivity	I:C0598941
differed	O
between	O
healthy	O
controls	O
and	O
the	O
anxiety	O
group	O
during	O
fear	O
learning	B:C0023185
(	O
ηp2	O
range	O
between	O
0.088	O
and	O
0.176	O
and	O
P	O
range	O
between	O
0.02	O
and	O
0.003	O
)	O
and	O
extinction	O
recall	O
(	O
ηp2	O
range	O
between	O
0.111	O
and	O
0.235	O
and	O
P	O
range	O
between	O
0.02	O
and	O
0.002	O
)	O
.	O

Psychophysiological	O
interaction	O
analyses	O
revealed	O
that	O
the	O
fear	O
network	O
connectivity	I:C0598941
differed	O
between	O
healthy	O
controls	O
and	O
the	O
anxiety	O
group	O
during	O
fear	O
learning	O
(	O
ηp2	O
range	O
between	O
0.088	O
and	O
0.176	O
and	O
P	O
range	O
between	O
0.02	O
and	O
0.003	O
)	O
and	O
extinction	B:C0015347
recall	O
(	O
ηp2	O
range	O
between	O
0.111	O
and	O
0.235	O
and	O
P	O
range	O
between	O
0.02	O
and	O
0.002	O
)	O
.	O

Psychophysiological	O
interaction	O
analyses	O
revealed	O
that	O
the	O
fear	O
network	O
connectivity	I:C0598941
differed	O
between	O
healthy	O
controls	O
and	O
the	O
anxiety	O
group	O
during	O
fear	O
learning	O
(	O
ηp2	O
range	O
between	O
0.088	O
and	O
0.176	O
and	O
P	O
range	O
between	O
0.02	O
and	O
0.003	O
)	O
and	O
extinction	O
recall	B:C0034770
(	O
ηp2	O
range	O
between	O
0.111	O
and	O
0.235	O
and	O
P	O
range	O
between	O
0.02	O
and	O
0.002	O
)	O
.	O

Despite	O
no	O
skin	O
conductance	O
response	O
group	B:C1257890
differences	O
during	O
extinction	O
recall	O
,	O
brain	O
activation	O
patterns	O
between	O
anxious	O
and	O
healthy	O
individuals	O
differed	O
.	O

Despite	O
no	O
skin	O
conductance	O
response	O
group	O
differences	O
during	O
extinction	B:C0015347
recall	O
,	O
brain	O
activation	O
patterns	O
between	O
anxious	O
and	O
healthy	O
individuals	O
differed	O
.	O

Despite	O
no	O
skin	O
conductance	O
response	O
group	O
differences	O
during	O
extinction	O
recall	B:C0034770
,	O
brain	O
activation	O
patterns	O
between	O
anxious	O
and	O
healthy	O
individuals	O
differed	O
.	O

Despite	O
no	O
skin	O
conductance	O
response	O
group	O
differences	O
during	O
extinction	O
recall	O
,	O
brain	B:C0006104
activation	O
patterns	O
between	O
anxious	O
and	O
healthy	O
individuals	O
differed	O
.	O

Despite	O
no	O
skin	O
conductance	O
response	O
group	O
differences	O
during	O
extinction	O
recall	O
,	O
brain	O
activation	O
patterns	B:C0449774
between	O
anxious	O
and	O
healthy	O
individuals	O
differed	O
.	O

Despite	O
no	O
skin	O
conductance	O
response	O
group	O
differences	O
during	O
extinction	O
recall	O
,	O
brain	O
activation	O
patterns	O
between	O
anxious	O
and	O
healthy	O
individuals	B:C0237401
differed	O
.	O

These	O
findings	B:C0243095
encourage	O
future	O
studies	O
to	O
examine	O
the	O
conditions	O
longitudinally	O
and	O
in	O
the	O
context	O
of	O
treatment	O
trials	I:C0008976
to	O
improve	O
and	O
guide	O
therapeutics	I:C1562629
via	O
advanced	O
neurobiological	O
understanding	O
of	O
each	O
disorder	O
.	O

These	O
findings	O
encourage	O
future	O
studies	B:C2603343
to	O
examine	O
the	O
conditions	O
longitudinally	O
and	O
in	O
the	O
context	O
of	O
treatment	O
trials	I:C0008976
to	O
improve	O
and	O
guide	O
therapeutics	I:C1562629
via	O
advanced	O
neurobiological	O
understanding	O
of	O
each	O
disorder	O
.	O

These	O
findings	O
encourage	O
future	O
studies	O
to	O
examine	B:C0582103
the	O
conditions	O
longitudinally	O
and	O
in	O
the	O
context	O
of	O
treatment	O
trials	I:C0008976
to	O
improve	O
and	O
guide	O
therapeutics	I:C1562629
via	O
advanced	O
neurobiological	O
understanding	O
of	O
each	O
disorder	O
.	O

These	O
findings	O
encourage	O
future	O
studies	O
to	O
examine	O
the	O
conditions	O
longitudinally	B:C0023981
and	O
in	O
the	O
context	O
of	O
treatment	O
trials	I:C0008976
to	O
improve	O
and	O
guide	O
therapeutics	I:C1562629
via	O
advanced	O
neurobiological	O
understanding	O
of	O
each	O
disorder	O
.	O

These	O
findings	O
encourage	O
future	O
studies	O
to	O
examine	O
the	O
conditions	O
longitudinally	O
and	O
in	O
the	O
context	O
of	O
treatment	B:C0008976
trials	I:C0008976
to	O
improve	O
and	O
guide	O
therapeutics	I:C1562629
via	O
advanced	O
neurobiological	O
understanding	O
of	O
each	O
disorder	O
.	O

These	O
findings	O
encourage	O
future	O
studies	O
to	O
examine	O
the	O
conditions	O
longitudinally	O
and	O
in	O
the	O
context	O
of	O
treatment	O
trials	I:C0008976
to	O
improve	B:C0184511
and	O
guide	O
therapeutics	I:C1562629
via	O
advanced	O
neurobiological	O
understanding	O
of	O
each	O
disorder	O
.	O

These	O
findings	O
encourage	O
future	O
studies	O
to	O
examine	O
the	O
conditions	O
longitudinally	O
and	O
in	O
the	O
context	O
of	O
treatment	O
trials	I:C0008976
to	O
improve	O
and	O
guide	B:C1562629
therapeutics	I:C1562629
via	O
advanced	O
neurobiological	O
understanding	O
of	O
each	O
disorder	O
.	O

These	O
findings	O
encourage	O
future	O
studies	O
to	O
examine	O
the	O
conditions	O
longitudinally	O
and	O
in	O
the	O
context	O
of	O
treatment	O
trials	I:C0008976
to	O
improve	O
and	O
guide	O
therapeutics	I:C1562629
via	O
advanced	O
neurobiological	B:C0027817
understanding	O
of	O
each	O
disorder	O
.	O

These	O
findings	O
encourage	O
future	O
studies	O
to	O
examine	O
the	O
conditions	O
longitudinally	O
and	O
in	O
the	O
context	O
of	O
treatment	O
trials	I:C0008976
to	O
improve	O
and	O
guide	O
therapeutics	I:C1562629
via	O
advanced	O
neurobiological	O
understanding	B:C0162340
of	O
each	O
disorder	O
.	O

These	O
findings	O
encourage	O
future	O
studies	O
to	O
examine	O
the	O
conditions	O
longitudinally	O
and	O
in	O
the	O
context	O
of	O
treatment	O
trials	I:C0008976
to	O
improve	O
and	O
guide	O
therapeutics	I:C1562629
via	O
advanced	O
neurobiological	O
understanding	O
of	O
each	O
disorder	B:C0012634
.	O

